Ritonavir

Intervention

7 papers5 findings

PubChemChEBI

  • 3 independent labs in 3 countries
  • Funders: National Institutes of Health and 3 more
  • Humans1
  • Animals2
  • Model organisms4

Outcomes

3

Lifespan

upin mice1upin worms1

2 studies
  1. Ritonavir extends lifespan in worms.

    “five compounds (all-trans retinoic acid, berberine, fisetin, propranolol, and ritonavir) extended lifespan in Caenorhabditis elegans.”

    Model organisms

    Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically-diverse Caenorhabditis nematodes

    eLife27 Dec 2024Preprint

  2. Ritonavir extends lifespan in mice.

    “A modest improvement in lifespan was associated with decreased cardiomyocyte brain natriuretic peptide (BNP) expression”

    Animalsin TG9 mice

    Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia

    Scientific reports24 Apr 2018

Cardiac output

upin mice1

1 study
  1. Ritonavir increases cardiac output in mice.

    “Chronic ritonavir also increased cardiac output and dV/dt-d in C57Bl/6 mice following ischemia-reperfusion injury.”

    Animalsfollowing ischemia-reperfusion injuryheart

    Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia

    Scientific reports24 Apr 2018

Glucose tolerance

upin mice1

1 study
  1. Ritonavir improves glucose tolerance in mice.

    “Glucose tolerance was significantly improved with chronic treatment”

    Animalsin TG9 mice

    Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia

    Scientific reports24 Apr 2018

Associations

1

Age advancement

upin humans1

1 study
  1. Ritonavir is associated with age advancement in humans.

    “age advancement in the 2000HIV cohort was positively associated with prior hepatitis C and cytomegalovirus (CMV) infections, non-AIDS-related comorbidities, ART duration, cumulative exposure to the protease inhibitor Ritonavir”

    Humansin PLHIV (2000HIV cohort)

    Plasma Proteomic Signature as a Predictor of Age Advancement in People Living With HIV

    Aging cell15 Jan 2025

More on Age advancement

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months